Back to Search
Start Over
COVID-19 and Hypercoagulability.
- Source :
-
Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2020 Jul; Vol. 18 (7), pp. 386-389. - Publication Year :
- 2020
- Subjects :
- Biomarkers blood
Blood Platelets drug effects
Blood Platelets immunology
Blood Platelets virology
COVID-19
Coronavirus Infections drug therapy
Coronavirus Infections mortality
Coronavirus Infections virology
Cytokine Release Syndrome drug therapy
Cytokine Release Syndrome mortality
Cytokine Release Syndrome virology
Disseminated Intravascular Coagulation drug therapy
Disseminated Intravascular Coagulation mortality
Disseminated Intravascular Coagulation virology
Factor VIII metabolism
Fibrin Fibrinogen Degradation Products metabolism
Fibrinogen metabolism
Humans
Pandemics
Pneumonia, Viral drug therapy
Pneumonia, Viral mortality
Pneumonia, Viral virology
SARS-CoV-2
Survival Analysis
von Willebrand Factor
Anticoagulants therapeutic use
Betacoronavirus pathogenicity
Coronavirus Infections immunology
Cytokine Release Syndrome immunology
Disseminated Intravascular Coagulation immunology
Pneumonia, Viral immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1543-0790
- Volume :
- 18
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Clinical advances in hematology & oncology : H&O
- Accession number :
- 32903249